Mesa Laboratories (MLAB) was Downgraded by Sidoti to ” Neutral”. Earlier the firm had a rating of “Buy ” on the company shares. Sidoti advised their investors in a research report released on Jun 10, 2016.
Mesa Laboratories opened for trading at $129.23 and hit $131.88 on the upside on Thursday, eventually ending the session at $130.55, with a gain of 0.69% or 0.89 points. The heightened volatility saw the trading volume jump to 26,845 shares. Company has a market cap of $475 M.
In a different news, on Jun 8, 2016, Glenn E Adriance (CSMO) sold 3,000 shares at $111.74 per share price. According to the SEC, on Mar 9, 2016, H Stuart Campbell (director) sold 280 shares at $90.00 per share price. On Nov 9, 2015, John James Sullivan (President and CEO) sold 2,400 shares at $112.99 per share price, according to the Form-4 filing with the securities and exchange commission.
Mesa Laboratories Inc. is primarily focused on quality control products. The Company has three segments: Instruments Biological Indicators and Continuous Monitoring. The Company’s Instruments segment designs manufactures and markets quality control instruments and disposable products utilized in connection with the healthcare pharmaceutical food and beverage medical device industrial hygiene environmental air sampling and semiconductor industries. Its Biological Indicators segment manufactures and markets biological indicators and distributes chemical indicators used to assess the effectiveness of sterilization processes in the hospital dental medical device and pharmaceutical industries. Its Continuous Monitoring segment designs develops and markets systems which are used to monitor various environmental parameters in hospitals pharmaceutical and medical device manufacturers blood banks pharmacies and a number of other laboratory and industrial environments.